Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Marchesoni, A.
Right arrow Articles by Battafarano, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marchesoni, A.
Right arrow Articles by Battafarano, N.
Related Collections
Right arrow Systemic Sclerosis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2003; 42: 1274
© 2003 British Society for Rheumatology

Letter to the Editor

Reply

A. Marchesoni, M. Arreghini, B. Panni and N. Battafarano

Department of Rheumatology, G. Pini Orthopaedic Institute, Milan, Italy

Correspondence to: A. Marchesoni, Department of Rheumatology, G. Pini Orthopaedic Institute, Via Pini 9, 20122 Milan, Italy. E-mail: marchesoni@gpini.it

The first 10% of the full text of this article appears below.

We read with interest this letter from Menon et al. [1] reporting another case of pancytopenia following infliximab infusion, . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?